Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
- Published In:
- Lancet (London, England), 402(10403), 705-719 (2023)
- Authors:
- Knop, Filip K(9), Aroda, Vanita R(4), do Vale, Ruben D, Holst-Hansen, Thomas, Laursen, Peter N, Rosenstock, Julio, Rubino, Domenica M, Garvey, W Timothy
- Database ID:
- RPEP-07052
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07052APA
Knop, Filip K; Aroda, Vanita R; do Vale, Ruben D; Holst-Hansen, Thomas; Laursen, Peter N; Rosenstock, Julio; Rubino, Domenica M; Garvey, W Timothy. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.. Lancet (London, England), 402(10403), 705-719. https://doi.org/10.1016/S0140-6736(23)01185-6
MLA
Knop, Filip K, et al. "Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.." Lancet (London, 2023. https://doi.org/10.1016/S0140-6736(23)01185-6
RethinkPeptides
RethinkPeptides Research Database. "Oral semaglutide 50 mg taken once per day in adults with ove..." RPEP-07052. Retrieved from https://rethinkpeptides.com/research/knop-2023-oral-semaglutide-50-mg
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.